chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Hypoxia, Oxygen saturation decreased, Pain, Prohormone brain natriuretic peptide
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/22/21 (ER8731) Pfizer Dose 2 5/14/21 (EW0168) COVID Positive 12/12/21  12/19/21: Patient is a 61-year-old male with a past medical history significant for COPD, hypertension, hepatitis-C, type 2 diabetes, BPH, OSA, obesity, tobacco user. The patient presents to the ED today with complaints of worsening shortness of breath. The patient states he tested positive for COVID-19 on 12/12/2021 and his symptoms began on 12/10/2021. The patient's accompanying symptoms include fatigue, generalized weakness, body aches, and cough. The patient denies fever, chills, sputum production, chest pain, nausea, vomiting or diarrhea.  The patient states he has used 15 albuterol nebulizer treatments since midnight last night due to shortness of breath. He states his shortness of breath worsens with exertion and he experiences dizziness and lightheadedness with ambulation. The patient is not vaccinated against COVID-19. He is an every day smoker, states he smokes about 0.5-1 packs per day. He denies any alcohol use or illicit drug abuse.   Upon arrival to ED patient's temperature is 99.2°, heart rate 108, respirations 22, pulse ox 92% on room air, blood pressure 132/94.  Patient was placed on 3 L oxygen via nasal cannula to maintain O2 saturations greater than 90% as patient had episode of desaturation with ambulation.  CT angio reveals no pulmonary embolism, patchy airspace disease in bilateral lungs likely represent viral pneumonia.  Patient's laboratory findings are significant for glucose 101, proBNP 197, d-dimer 0.70.  500 mg IV azithromycin, 1 g IV Rocephin, 125 mg IV Solu-Medrol, and DuoNeb x1 in the ED.  12/23/21: -Patient is a 61 yo male who is unvaccinated against COVID  who was being managed for COVID pneumonia with hypoxia  -He was managed with Ceftriaxone , Azithromycin , Decadron and remdesivir  -His symptoms improved  -Home oxygen test done showed he requires 3L oxygen on exertion and none at rest  -He will be discharged with 1 day course of levaquin, 7 days of decadron and covid supportive treatments  -Patient will be discharged.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/22/21 (ER8731) Pfizer Dose 2 5/14/21 (EW0168) COVID Positive 12/12/21  12/19/21: Patient is a 61-year-old male with a past medical history significant for COPD, hypertension, hepatitis-C, type 2 diabetes, BPH, OSA, obesity, tobacco user. The patient presents to the ED today with complaints of worsening shortness of breath. The patient states he tested positive for COVID-19 on 12/12/2021 and his symptoms began on 12/10/2021. The patient's accompanying symptoms include fatigue, generalized weakness, body aches, and cough. The patient denies fever, chills, sputum production, chest pain, nausea, vomiting or diarrhea.  The patient states he has used 15 albuterol nebulizer treatments since midnight last night due to shortness of breath. He states his shortness of breath worsens with exertion and he experiences dizziness and lightheadedness with ambulation. The patient is not vaccinated against COVID-19. He is an every day smoker, states he smokes about 0.5-1 packs per day. He denies any alcohol use or illicit drug abuse.   Upon arrival to ED patient's temperature is 99.2°, heart rate 108, respirations 22, pulse ox 92% on room air, blood pressure 132/94.  Patient was placed on 3 L oxygen via nasal cannula to maintain O2 saturations greater than 90% as patient had episode of desaturation with ambulation.  CT angio reveals no pulmonary embolism, patchy airspace disease in bilateral lungs likely represent viral pneumonia.  Patient's laboratory findings are significant for glucose 101, proBNP 197, d-dimer 0.70.  500 mg IV azithromycin, 1 g IV Rocephin, 125 mg IV Solu-Medrol, and DuoNeb x1 in the ED.  12/23/21: -Patient is a 61 yo male who is unvaccinated against COVID  who was being managed for COVID pneumonia with hypoxia  -He was managed with Ceftriaxone , Azithromycin , Decadron and remdesivir  -His symptoms improved  -Home oxygen test done showed he requires 3L oxygen on exertion and none at rest  -He will be discharged with 1 day course of levaquin, 7 days of decadron and covid supportive treatments  -Patient will be discharged.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Condition aggravated, Exposure to SARS-CoV-2, Facial pain
Clinical narrative: I had my fourth Pfizer shot on 4/6/2022. I suffer from seasonal allergies every year. About two weeks after my shot, my allergies worsened and I was concurrently exposed to Covid. My son, husband, daughter, daughter-in-law, cousin and grandson all tested positive between 4/16/2022 and 4/19/2022 (rapid Antigen home test). I tested negative but was having either mild covid symptoms or allergies (sore throat and "stuffed" sinuses. On 4/22/2022 I went for a PCR test which tested positive.  On 5/3/2022 I tested negative (home rapid Antigen test). I continued to have mild symptoms and fatigue so  called my doctor on 5/6/2022 as my left cheek and teeth hurt and my nose dripped yellow snot. She started me on a Zpack.  On 5/10/2022 I flew (for the first time since covid and wore a mask during the journey) During that period I was away, I had mild fatigue, chills at night, sore throat. I went to see the doctor on 5/17/2022. She confirmed the sinus infection still present and started me on a three day course of Prednisone and a new antibiotic (Cefuroxime). I am beginning to feel better.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Malaise, Nasal congestion, Nasal discharge discolouration, Oropharyngeal pain
Clinical narrative: I had my fourth Pfizer shot on 4/6/2022. I suffer from seasonal allergies every year. About two weeks after my shot, my allergies worsened and I was concurrently exposed to Covid. My son, husband, daughter, daughter-in-law, cousin and grandson all tested positive between 4/16/2022 and 4/19/2022 (rapid Antigen home test). I tested negative but was having either mild covid symptoms or allergies (sore throat and "stuffed" sinuses. On 4/22/2022 I went for a PCR test which tested positive.  On 5/3/2022 I tested negative (home rapid Antigen test). I continued to have mild symptoms and fatigue so  called my doctor on 5/6/2022 as my left cheek and teeth hurt and my nose dripped yellow snot. She started me on a Zpack.  On 5/10/2022 I flew (for the first time since covid and wore a mask during the journey) During that period I was away, I had mild fatigue, chills at night, sore throat. I went to see the doctor on 5/17/2022. She confirmed the sinus infection still present and started me on a three day course of Prednisone and a new antibiotic (Cefuroxime). I am beginning to feel better.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test negative, SARS-CoV-2 test positive, Seasonal allergy, Sinusitis
Clinical narrative: I had my fourth Pfizer shot on 4/6/2022. I suffer from seasonal allergies every year. About two weeks after my shot, my allergies worsened and I was concurrently exposed to Covid. My son, husband, daughter, daughter-in-law, cousin and grandson all tested positive between 4/16/2022 and 4/19/2022 (rapid Antigen home test). I tested negative but was having either mild covid symptoms or allergies (sore throat and "stuffed" sinuses. On 4/22/2022 I went for a PCR test which tested positive.  On 5/3/2022 I tested negative (home rapid Antigen test). I continued to have mild symptoms and fatigue so  called my doctor on 5/6/2022 as my left cheek and teeth hurt and my nose dripped yellow snot. She started me on a Zpack.  On 5/10/2022 I flew (for the first time since covid and wore a mask during the journey) During that period I was away, I had mild fatigue, chills at night, sore throat. I went to see the doctor on 5/17/2022. She confirmed the sinus infection still present and started me on a three day course of Prednisone and a new antibiotic (Cefuroxime). I am beginning to feel better.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Toothache
Clinical narrative: I had my fourth Pfizer shot on 4/6/2022. I suffer from seasonal allergies every year. About two weeks after my shot, my allergies worsened and I was concurrently exposed to Covid. My son, husband, daughter, daughter-in-law, cousin and grandson all tested positive between 4/16/2022 and 4/19/2022 (rapid Antigen home test). I tested negative but was having either mild covid symptoms or allergies (sore throat and "stuffed" sinuses. On 4/22/2022 I went for a PCR test which tested positive.  On 5/3/2022 I tested negative (home rapid Antigen test). I continued to have mild symptoms and fatigue so  called my doctor on 5/6/2022 as my left cheek and teeth hurt and my nose dripped yellow snot. She started me on a Zpack.  On 5/10/2022 I flew (for the first time since covid and wore a mask during the journey) During that period I was away, I had mild fatigue, chills at night, sore throat. I went to see the doctor on 5/17/2022. She confirmed the sinus infection still present and started me on a three day course of Prednisone and a new antibiotic (Cefuroxime). I am beginning to feel better.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Angiotensin converting enzyme normal, Antinuclear antibody increased, Arthralgia, Blood thyroid stimulating hormone increased, Borrelia test negative
Clinical narrative: I started to have bilateral joint paint. I developed Iritis, a lot of fatigue, and my TSH hormone blood value stayed elevated. I went to see my eye doctor for the Iritis. It was a lot of eye pain and my eye got very blood shot. After a couple of appointments, He thought it was suspect because I was experiencing it for a long period of time. He told me to go see my primary doctor. I do remember having extreme fatigue early on in the pandemic and because of that I had to use my inhaler very frequently. Then my primary doctor also thought my body reacted strongly to the vaccination because I might have had COVID-19. I was referred to rheumatologist and they did some test and showed that my body was in an autoimmune response. Some the blood values had decreased and have started to stabilize. I continue to have the bilateral joint pain and fatigue. I am currently experiencing another bout of the Iritis.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: C-reactive protein increased, Eye pain, Fatigue, Iritis, Ocular hyperaemia
Clinical narrative: I started to have bilateral joint paint. I developed Iritis, a lot of fatigue, and my TSH hormone blood value stayed elevated. I went to see my eye doctor for the Iritis. It was a lot of eye pain and my eye got very blood shot. After a couple of appointments, He thought it was suspect because I was experiencing it for a long period of time. He told me to go see my primary doctor. I do remember having extreme fatigue early on in the pandemic and because of that I had to use my inhaler very frequently. Then my primary doctor also thought my body reacted strongly to the vaccination because I might have had COVID-19. I was referred to rheumatologist and they did some test and showed that my body was in an autoimmune response. Some the blood values had decreased and have started to stabilize. I continue to have the bilateral joint pain and fatigue. I am currently experiencing another bout of the Iritis.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate increased, Thyroxine free normal
Clinical narrative: I started to have bilateral joint paint. I developed Iritis, a lot of fatigue, and my TSH hormone blood value stayed elevated. I went to see my eye doctor for the Iritis. It was a lot of eye pain and my eye got very blood shot. After a couple of appointments, He thought it was suspect because I was experiencing it for a long period of time. He told me to go see my primary doctor. I do remember having extreme fatigue early on in the pandemic and because of that I had to use my inhaler very frequently. Then my primary doctor also thought my body reacted strongly to the vaccination because I might have had COVID-19. I was referred to rheumatologist and they did some test and showed that my body was in an autoimmune response. Some the blood values had decreased and have started to stabilize. I continue to have the bilateral joint pain and fatigue. I am currently experiencing another bout of the Iritis.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Aerococcus urinae infection, Asthenia, COVID-19, Chest X-ray abnormal, Fatigue
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 2/15/21 (en6201) Pfizer Dose 2 3/11/21 (EN6205) Pfizer Dose 3 12/2/21 (FH8027) COVID Positive 12/21/21  12/21/21: The patient complaining from generalized weakness and fatigue, decline fever or chills or cough or shortness of breath or abdominal pain or nausea or vomiting or diarrhea, no chest pain or palpitation. The patient is vaccinated for COVID-19. His labs show stable CKD, he does have pyuria, chest x-ray show possible pneumonia.  COVID-19 test is positive.  12/27/21: The patient admitted for worsening COVID symptoms and Aerococcus UTI s/p Ceftriaxone course  The patient is vaccinated for COVID-19.  Patient not requiring oxygen during hospitalization but had respiratory insufficiency while ambulating  He was managed with IV steroids. No remdesivir given because of kidney function  Patient's symptoms improved. He is hemodyanmiclly stable  Patient accepted at home and will be discharged today
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Pyuria, Renal impairment, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 2/15/21 (en6201) Pfizer Dose 2 3/11/21 (EN6205) Pfizer Dose 3 12/2/21 (FH8027) COVID Positive 12/21/21  12/21/21: The patient complaining from generalized weakness and fatigue, decline fever or chills or cough or shortness of breath or abdominal pain or nausea or vomiting or diarrhea, no chest pain or palpitation. The patient is vaccinated for COVID-19. His labs show stable CKD, he does have pyuria, chest x-ray show possible pneumonia.  COVID-19 test is positive.  12/27/21: The patient admitted for worsening COVID symptoms and Aerococcus UTI s/p Ceftriaxone course  The patient is vaccinated for COVID-19.  Patient not requiring oxygen during hospitalization but had respiratory insufficiency while ambulating  He was managed with IV steroids. No remdesivir given because of kidney function  Patient's symptoms improved. He is hemodyanmiclly stable  Patient accepted at home and will be discharged today
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 2/15/21 (en6201) Pfizer Dose 2 3/11/21 (EN6205) Pfizer Dose 3 12/2/21 (FH8027) COVID Positive 12/21/21  12/21/21: The patient complaining from generalized weakness and fatigue, decline fever or chills or cough or shortness of breath or abdominal pain or nausea or vomiting or diarrhea, no chest pain or palpitation. The patient is vaccinated for COVID-19. His labs show stable CKD, he does have pyuria, chest x-ray show possible pneumonia.  COVID-19 test is positive.  12/27/21: The patient admitted for worsening COVID symptoms and Aerococcus UTI s/p Ceftriaxone course  The patient is vaccinated for COVID-19.  Patient not requiring oxygen during hospitalization but had respiratory insufficiency while ambulating  He was managed with IV steroids. No remdesivir given because of kidney function  Patient's symptoms improved. He is hemodyanmiclly stable  Patient accepted at home and will be discharged today
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Anticoagulant therapy, Asthenia, Blood test normal, COVID-19
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 (EN6201) Pfizer Dose 2 (EN6199) COVID Positive 12/19/21  12/19/21: A 79-year-old female with past medical history of COPD  not on home oxygen, hypertension the stage IIIB CKD, status post recent AAA repair at clinic in July 2021 comes to ED complaining of generalized weakness.  Patient states that she has not been feeling well for almost 3 weeks.  Had diarrhea for almost 2 weeks, multiple episodes of loose stools, but it has resolved about a week ago.  She does have loss of appetite and poor oral intake.  Denies vomiting or abdominal pain.  Does have some chronic cough, mostly nonproductive.  Patient states she is always short of breath due to COPD, nothing worse now.  Denies fever or chills or dysuria or hematuria.  Patient is vaccinated against COVID-19, had 2 doses, but not the booster.  Denies sick contacts.   On arrival in the ED, she was afebrile, vital signs stable and pulse ox was 91% on room air.  Abdomen acute series was done, reported as no abnormality.  Blood work is unremarkable except for stable renal function and chronic anemia.  With ambulation her oxygenation dropped in the ED, placed on 2 L oxygen by NC.  COVID-19 rapid antigen and influenza a are tested positive.  She has not received any treatment in the ED.  12/22/21: 79-year-old woman who presented to the emergency department with complaints of worsening generalized weakness and malaise, resolved diarrhea, cough.  Oxygen saturation was noted to drop to hypoxic levels with ambulation however chest x-ray demonstrated clear lung fields.  COVID-19 PCR was positive, influenza A antigen screen was also positive.  She was started on supplemental oxygen, treated with Tamiflu and parenteral steroid therapy.  Renal function precluded administration of IV remdesivir, low-dose anticoagulation was initiated on account of elevated D-dimers.  Clinical response was favorable with gradual improvement in oxygen requirements, generalized weakness and malaise.  She was evaluated by Physical therapy and cleared for discharge home with home health services.  Oxygen walk for home determination done prior to discharge revealed that she did not meet criteria for home oxygen.  She is in stable medical condition at the time of discharge.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray normal, Cough, Decreased appetite, Diarrhoea, Dyspnoea
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 (EN6201) Pfizer Dose 2 (EN6199) COVID Positive 12/19/21  12/19/21: A 79-year-old female with past medical history of COPD  not on home oxygen, hypertension the stage IIIB CKD, status post recent AAA repair at clinic in July 2021 comes to ED complaining of generalized weakness.  Patient states that she has not been feeling well for almost 3 weeks.  Had diarrhea for almost 2 weeks, multiple episodes of loose stools, but it has resolved about a week ago.  She does have loss of appetite and poor oral intake.  Denies vomiting or abdominal pain.  Does have some chronic cough, mostly nonproductive.  Patient states she is always short of breath due to COPD, nothing worse now.  Denies fever or chills or dysuria or hematuria.  Patient is vaccinated against COVID-19, had 2 doses, but not the booster.  Denies sick contacts.   On arrival in the ED, she was afebrile, vital signs stable and pulse ox was 91% on room air.  Abdomen acute series was done, reported as no abnormality.  Blood work is unremarkable except for stable renal function and chronic anemia.  With ambulation her oxygenation dropped in the ED, placed on 2 L oxygen by NC.  COVID-19 rapid antigen and influenza a are tested positive.  She has not received any treatment in the ED.  12/22/21: 79-year-old woman who presented to the emergency department with complaints of worsening generalized weakness and malaise, resolved diarrhea, cough.  Oxygen saturation was noted to drop to hypoxic levels with ambulation however chest x-ray demonstrated clear lung fields.  COVID-19 PCR was positive, influenza A antigen screen was also positive.  She was started on supplemental oxygen, treated with Tamiflu and parenteral steroid therapy.  Renal function precluded administration of IV remdesivir, low-dose anticoagulation was initiated on account of elevated D-dimers.  Clinical response was favorable with gradual improvement in oxygen requirements, generalized weakness and malaise.  She was evaluated by Physical therapy and cleared for discharge home with home health services.  Oxygen walk for home determination done prior to discharge revealed that she did not meet criteria for home oxygen.  She is in stable medical condition at the time of discharge.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Hypophagia, Hypoxia, Influenza A virus test positive, Malaise
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 (EN6201) Pfizer Dose 2 (EN6199) COVID Positive 12/19/21  12/19/21: A 79-year-old female with past medical history of COPD  not on home oxygen, hypertension the stage IIIB CKD, status post recent AAA repair at clinic in July 2021 comes to ED complaining of generalized weakness.  Patient states that she has not been feeling well for almost 3 weeks.  Had diarrhea for almost 2 weeks, multiple episodes of loose stools, but it has resolved about a week ago.  She does have loss of appetite and poor oral intake.  Denies vomiting or abdominal pain.  Does have some chronic cough, mostly nonproductive.  Patient states she is always short of breath due to COPD, nothing worse now.  Denies fever or chills or dysuria or hematuria.  Patient is vaccinated against COVID-19, had 2 doses, but not the booster.  Denies sick contacts.   On arrival in the ED, she was afebrile, vital signs stable and pulse ox was 91% on room air.  Abdomen acute series was done, reported as no abnormality.  Blood work is unremarkable except for stable renal function and chronic anemia.  With ambulation her oxygenation dropped in the ED, placed on 2 L oxygen by NC.  COVID-19 rapid antigen and influenza a are tested positive.  She has not received any treatment in the ED.  12/22/21: 79-year-old woman who presented to the emergency department with complaints of worsening generalized weakness and malaise, resolved diarrhea, cough.  Oxygen saturation was noted to drop to hypoxic levels with ambulation however chest x-ray demonstrated clear lung fields.  COVID-19 PCR was positive, influenza A antigen screen was also positive.  She was started on supplemental oxygen, treated with Tamiflu and parenteral steroid therapy.  Renal function precluded administration of IV remdesivir, low-dose anticoagulation was initiated on account of elevated D-dimers.  Clinical response was favorable with gradual improvement in oxygen requirements, generalized weakness and malaise.  She was evaluated by Physical therapy and cleared for discharge home with home health services.  Oxygen walk for home determination done prior to discharge revealed that she did not meet criteria for home oxygen.  She is in stable medical condition at the time of discharge.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 (EN6201) Pfizer Dose 2 (EN6199) COVID Positive 12/19/21  12/19/21: A 79-year-old female with past medical history of COPD  not on home oxygen, hypertension the stage IIIB CKD, status post recent AAA repair at clinic in July 2021 comes to ED complaining of generalized weakness.  Patient states that she has not been feeling well for almost 3 weeks.  Had diarrhea for almost 2 weeks, multiple episodes of loose stools, but it has resolved about a week ago.  She does have loss of appetite and poor oral intake.  Denies vomiting or abdominal pain.  Does have some chronic cough, mostly nonproductive.  Patient states she is always short of breath due to COPD, nothing worse now.  Denies fever or chills or dysuria or hematuria.  Patient is vaccinated against COVID-19, had 2 doses, but not the booster.  Denies sick contacts.   On arrival in the ED, she was afebrile, vital signs stable and pulse ox was 91% on room air.  Abdomen acute series was done, reported as no abnormality.  Blood work is unremarkable except for stable renal function and chronic anemia.  With ambulation her oxygenation dropped in the ED, placed on 2 L oxygen by NC.  COVID-19 rapid antigen and influenza a are tested positive.  She has not received any treatment in the ED.  12/22/21: 79-year-old woman who presented to the emergency department with complaints of worsening generalized weakness and malaise, resolved diarrhea, cough.  Oxygen saturation was noted to drop to hypoxic levels with ambulation however chest x-ray demonstrated clear lung fields.  COVID-19 PCR was positive, influenza A antigen screen was also positive.  She was started on supplemental oxygen, treated with Tamiflu and parenteral steroid therapy.  Renal function precluded administration of IV remdesivir, low-dose anticoagulation was initiated on account of elevated D-dimers.  Clinical response was favorable with gradual improvement in oxygen requirements, generalized weakness and malaise.  She was evaluated by Physical therapy and cleared for discharge home with home health services.  Oxygen walk for home determination done prior to discharge revealed that she did not meet criteria for home oxygen.  She is in stable medical condition at the time of discharge.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Aphonia, COVID-19, Cough, Malaise, Rhinorrhoea
Clinical narrative: I started getting symptoms of scratchy throat, runny nose, cough, general malaise. The next day, I took an at home COVID-19 test that was positive. I was prescribed Molnupiravir on 5/16/2022 by my doctor which has seemed to help my symptoms. I feel better today and my voice is back.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Throat irritation
Clinical narrative: I started getting symptoms of scratchy throat, runny nose, cough, general malaise. The next day, I took an at home COVID-19 test that was positive. I was prescribed Molnupiravir on 5/16/2022 by my doctor which has seemed to help my symptoms. I feel better today and my voice is back.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Basedow's disease, Blood test abnormal
Clinical narrative: I was diagnose with Grave's disease and was prescribed Methimazole.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Approximately 3 weeks after my 2nd dose vaccination, I experienced the following symptoms: Shoulder pain (Left side). I had a cortisone shot for treatment and have an upcoming MRI appointment to determine what is happening with my shoulder.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Cardiac failure congestive, Cardiomegaly, Chills
Clinical narrative: COVID Vaccine Breakthrough Dose  Pfizer Dose 1 2/8/21 (el3302) Pfizer Dose 2 3/2/21 (EN6200) Pfizer Dose 3 8/24/21 (EW0177) COVID Positive 12/17/21 COVID Positive 12/26/21  12/24/21: 85-year-old female with pulmonary MAC and bronchiectasis on chronic antibiotics, rheumatoid arthritis and Sjogren syndrome on DMARD, achalasia status post EGD with Botox injection, IBS, severe pulmonary hypertension presented with worsening shortness of breath and cough. Symptoms started about 10 days ago and patient tested for COVID-19 on 12/17 and received monoclonal antibody infusion as an outpatient.  Symptoms  progressively worsened with increasing shortness of breath, dyspnea with exertion and cough productive of blood-tinged sputum.  Patient reports she is usually very active however felt weak and tired. Had fever and chills.  She received both COVID vaccines as well as booster dose.  In the ED patient was afebrile, hemodynamically stable requiring 2 L of oxygen.  Chest CT showed no pulmonary embolism noted bilateral ground-glass airspace disease suggestive of viral pneumonia, patient also have cardiomegaly with findings suggestive of Congestive Heart Failure.  12/28/21: Patient was admitted and started on supplemental oxygen as well as remdesivir, dexamethasone, and Zosyn with doxycycline.  She was also placed on Lasix 20 mg daily. She had slow improvement in her oxygen requirements and was able to be weaned to room air at the time of discharge. She was kept on Zosyn while inpatient and will discharge on Augmentin for 3 additional days.  She also discharge with 3 additional days of Decadron 6 mg daily.  She felt well and will discharge with home health.  She should follow-up with her PCP as well as her regular pulmonologist.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram thorax abnormal, Decreased activity, Dyspnoea, Dyspnoea exertional, Fatigue
Clinical narrative: COVID Vaccine Breakthrough Dose  Pfizer Dose 1 2/8/21 (el3302) Pfizer Dose 2 3/2/21 (EN6200) Pfizer Dose 3 8/24/21 (EW0177) COVID Positive 12/17/21 COVID Positive 12/26/21  12/24/21: 85-year-old female with pulmonary MAC and bronchiectasis on chronic antibiotics, rheumatoid arthritis and Sjogren syndrome on DMARD, achalasia status post EGD with Botox injection, IBS, severe pulmonary hypertension presented with worsening shortness of breath and cough. Symptoms started about 10 days ago and patient tested for COVID-19 on 12/17 and received monoclonal antibody infusion as an outpatient.  Symptoms  progressively worsened with increasing shortness of breath, dyspnea with exertion and cough productive of blood-tinged sputum.  Patient reports she is usually very active however felt weak and tired. Had fever and chills.  She received both COVID vaccines as well as booster dose.  In the ED patient was afebrile, hemodynamically stable requiring 2 L of oxygen.  Chest CT showed no pulmonary embolism noted bilateral ground-glass airspace disease suggestive of viral pneumonia, patient also have cardiomegaly with findings suggestive of Congestive Heart Failure.  12/28/21: Patient was admitted and started on supplemental oxygen as well as remdesivir, dexamethasone, and Zosyn with doxycycline.  She was also placed on Lasix 20 mg daily. She had slow improvement in her oxygen requirements and was able to be weaned to room air at the time of discharge. She was kept on Zosyn while inpatient and will discharge on Augmentin for 3 additional days.  She also discharge with 3 additional days of Decadron 6 mg daily.  She felt well and will discharge with home health.  She should follow-up with her PCP as well as her regular pulmonologist.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Haemoptysis, Lung disorder, Lung opacity, Malaise, Pneumonia viral
Clinical narrative: COVID Vaccine Breakthrough Dose  Pfizer Dose 1 2/8/21 (el3302) Pfizer Dose 2 3/2/21 (EN6200) Pfizer Dose 3 8/24/21 (EW0177) COVID Positive 12/17/21 COVID Positive 12/26/21  12/24/21: 85-year-old female with pulmonary MAC and bronchiectasis on chronic antibiotics, rheumatoid arthritis and Sjogren syndrome on DMARD, achalasia status post EGD with Botox injection, IBS, severe pulmonary hypertension presented with worsening shortness of breath and cough. Symptoms started about 10 days ago and patient tested for COVID-19 on 12/17 and received monoclonal antibody infusion as an outpatient.  Symptoms  progressively worsened with increasing shortness of breath, dyspnea with exertion and cough productive of blood-tinged sputum.  Patient reports she is usually very active however felt weak and tired. Had fever and chills.  She received both COVID vaccines as well as booster dose.  In the ED patient was afebrile, hemodynamically stable requiring 2 L of oxygen.  Chest CT showed no pulmonary embolism noted bilateral ground-glass airspace disease suggestive of viral pneumonia, patient also have cardiomegaly with findings suggestive of Congestive Heart Failure.  12/28/21: Patient was admitted and started on supplemental oxygen as well as remdesivir, dexamethasone, and Zosyn with doxycycline.  She was also placed on Lasix 20 mg daily. She had slow improvement in her oxygen requirements and was able to be weaned to room air at the time of discharge. She was kept on Zosyn while inpatient and will discharge on Augmentin for 3 additional days.  She also discharge with 3 additional days of Decadron 6 mg daily.  She felt well and will discharge with home health.  She should follow-up with her PCP as well as her regular pulmonologist.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Productive cough, Pyrexia, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID Vaccine Breakthrough Dose  Pfizer Dose 1 2/8/21 (el3302) Pfizer Dose 2 3/2/21 (EN6200) Pfizer Dose 3 8/24/21 (EW0177) COVID Positive 12/17/21 COVID Positive 12/26/21  12/24/21: 85-year-old female with pulmonary MAC and bronchiectasis on chronic antibiotics, rheumatoid arthritis and Sjogren syndrome on DMARD, achalasia status post EGD with Botox injection, IBS, severe pulmonary hypertension presented with worsening shortness of breath and cough. Symptoms started about 10 days ago and patient tested for COVID-19 on 12/17 and received monoclonal antibody infusion as an outpatient.  Symptoms  progressively worsened with increasing shortness of breath, dyspnea with exertion and cough productive of blood-tinged sputum.  Patient reports she is usually very active however felt weak and tired. Had fever and chills.  She received both COVID vaccines as well as booster dose.  In the ED patient was afebrile, hemodynamically stable requiring 2 L of oxygen.  Chest CT showed no pulmonary embolism noted bilateral ground-glass airspace disease suggestive of viral pneumonia, patient also have cardiomegaly with findings suggestive of Congestive Heart Failure.  12/28/21: Patient was admitted and started on supplemental oxygen as well as remdesivir, dexamethasone, and Zosyn with doxycycline.  She was also placed on Lasix 20 mg daily. She had slow improvement in her oxygen requirements and was able to be weaned to room air at the time of discharge. She was kept on Zosyn while inpatient and will discharge on Augmentin for 3 additional days.  She also discharge with 3 additional days of Decadron 6 mg daily.  She felt well and will discharge with home health.  She should follow-up with her PCP as well as her regular pulmonologist.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, COVID-19, General physical condition abnormal, Glassy eyes, Insomnia
Clinical narrative: On Tuesday night I was not able to sleep well and had nasal congestion and my back was sore. I had been out weeding and thought maybe it was allergies from being in the garden. I had been at a wedding over the weekend but was very cautious. I went to work and my co-workers thought my eyes looked glassy and I just didn't look right. I took a test and it was positive. I called my Dr who had me test again two hours later and he got me Paxlovid. I really only had the body aches, I had a fever Wednesday night.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: On Tuesday night I was not able to sleep well and had nasal congestion and my back was sore. I had been out weeding and thought maybe it was allergies from being in the garden. I had been at a wedding over the weekend but was very cautious. I went to work and my co-workers thought my eyes looked glassy and I just didn't look right. I took a test and it was positive. I called my Dr who had me test again two hours later and he got me Paxlovid. I really only had the body aches, I had a fever Wednesday night.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Headache, Myalgia, Nausea, Vomiting
Clinical narrative: muscle ache, nausea, headache/pressure and emesis x's 2 (bile)
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Eating disorder, Fatigue, Increased upper airway secretion
Clinical narrative: About 6 months post booster shot came down with COVID-19. Evening of April 29, began having horrible sore throat. Used OTC drugs for sore throat with minimal relief. April 30th, throat pain was much worse and could hardly eat. Also began have thick white mucus and fever in the evening time. May 1st, had fever all day and the highest it got was 102. May 2nd, went to see doctor. Tested positive for COVID-19. Wednesday May 4th, symptoms began to resolve but coughing began. Thursday May 5th, fever free. May 7th-8th, all symptoms resolved. Still experienced fatigue off and on. Also began having very short spells of vertigo.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia, SARS-CoV-2 test positive, Vertigo
Clinical narrative: About 6 months post booster shot came down with COVID-19. Evening of April 29, began having horrible sore throat. Used OTC drugs for sore throat with minimal relief. April 30th, throat pain was much worse and could hardly eat. Also began have thick white mucus and fever in the evening time. May 1st, had fever all day and the highest it got was 102. May 2nd, went to see doctor. Tested positive for COVID-19. Wednesday May 4th, symptoms began to resolve but coughing began. Thursday May 5th, fever free. May 7th-8th, all symptoms resolved. Still experienced fatigue off and on. Also began having very short spells of vertigo.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood sodium decreased, COVID-19, Echocardiogram normal, Ejection fraction normal
Clinical narrative: Discharge Provider:  DO Primary Care Provider at Discharge:  MD  Admission Date: 5/12/2022 Discharge Date: 05/14/2022  PRESENTING PROBLEM: Hyponatremia  Weakness  COVID-19    HOSPITAL COURSE: Patient is an 85-year-old female who presented to the emergency department with generalized weakness.  In the emergency department, vital signs were stable.  She was found to be COVID-19 positive.  She was also found to have a sodium of 124. She was also noted to have some elevated troponins.  She was admitted to the Internal Medicine service with a Cardiology consult.  Cardiology felt elevated troponin likely was secondary to myocardial injury in the setting of COVID-19 and hyponatremia.  Echo was obtained and revealed EF 69% with normal LV function. They did not recommend any further testing.  Patient's sodium did improve with some IV fluids.  She was evaluated by therapy who recommended home with assist.  Patient was recommended to follow up with her primary care physician.  She was discharged home in stable condition.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Hyponatraemia, Myocardial injury, SARS-CoV-2 test positive, Troponin increased
Clinical narrative: Discharge Provider:  DO Primary Care Provider at Discharge:  MD  Admission Date: 5/12/2022 Discharge Date: 05/14/2022  PRESENTING PROBLEM: Hyponatremia  Weakness  COVID-19    HOSPITAL COURSE: Patient is an 85-year-old female who presented to the emergency department with generalized weakness.  In the emergency department, vital signs were stable.  She was found to be COVID-19 positive.  She was also found to have a sodium of 124. She was also noted to have some elevated troponins.  She was admitted to the Internal Medicine service with a Cardiology consult.  Cardiology felt elevated troponin likely was secondary to myocardial injury in the setting of COVID-19 and hyponatremia.  Echo was obtained and revealed EF 69% with normal LV function. They did not recommend any further testing.  Patient's sodium did improve with some IV fluids.  She was evaluated by therapy who recommended home with assist.  Patient was recommended to follow up with her primary care physician.  She was discharged home in stable condition.
Age: 86.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Intensive care, Pneumonia, SARS-CoV-2 test positive
Clinical narrative: Received Pfizer vaccines on 1/27/21, 2/17/21, 10/21/21, 5/12/22; tested positive for COVID by PCR on 5/19/22; admitted to hospital ICU on 5/19/22 d/t pneumonia d/t COVID19. PMH of COPD/asthma, heart failure, pulmonary HTN.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport  refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: patient given a dose of Pfizer vaccine that was in the fridge in syringe from the day prior. it had expired at 2030 on 5/19/22 and was administered 5/20/22 around 10 am because the nurse did not check the date on the syringe label and assumed it had been drawn up on 5/20/22 AM. Submitted safety report at facility and contacting pharmacy and nurse education coordinator.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Headache, Injection site pain, Pain
Clinical narrative: I started having symptoms of sinus issues with headache, runny nose, fatigue on 5-10-2022. On 5-11, I started running fever up to 100.0 with body aches. I took a home test for Covid on 5-12 and it was positive. I called the doctor on the same day and asked her for treatment. She called in Paxlovid and I took it for 5 days. Then I took another home test on 5-17 and it was negative. I have since taken two more home tests with one faint positive and the second showed negative. I did experience extreme fatigue and soreness at injection site after dose 4 Pfizer. I am reporting my breakthrough case of Covid.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive, Sinus disorder, Vaccine breakthrough infection
Clinical narrative: I started having symptoms of sinus issues with headache, runny nose, fatigue on 5-10-2022. On 5-11, I started running fever up to 100.0 with body aches. I took a home test for Covid on 5-12 and it was positive. I called the doctor on the same day and asked her for treatment. She called in Paxlovid and I took it for 5 days. Then I took another home test on 5-17 and it was negative. I have since taken two more home tests with one faint positive and the second showed negative. I did experience extreme fatigue and soreness at injection site after dose 4 Pfizer. I am reporting my breakthrough case of Covid.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Patient was administered an undiluted dose of Pfizer Vaccine.  PCP was notified. Mom was called and informed of error and given instructions on what to monitor for.
Age: 6.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, SARS-CoV-2 test positive
Clinical narrative: Received Pfizer vaccines on 11/9/21, 12/7/21. Tested positive for COVID by PCR on 5/15/22. Admitted to hospital on 5/19/22 d/t COVID pneumonia. History of mild persistent asthma.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Nasal congestion, Nausea, Pain
Clinical narrative: I did not have an adverse reaction to the vaccine but contracted Covid in May. I was Covid positive in January 2021 too. Took Bamlanivimab for Covid in January and I took Bebtelovimab in May. They both worked really well. Scratching throat, the sore throat got worse, I had stuffy nose, nausea, fatigue and body aches in both cases.